Cited by — Measurable residual disease-guided, fixed-duration, potentially definitive therapy for standard risk newly diagnosed multiple myeloma | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Measurable residual disease-guided, fixed-duration, potentially definitive therapy for standard risk newly diagnosed multiple myeloma.
No admitted local citation edges point to this work yet.
